Item 2.02 Results of Operations and Financial Condition.

On February 18, 2020, bluebird bio, Inc. announced its financial results for the year and three months ended December 31, 2019. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits
   Exhibit                                           Description
     No.
     99.1              Press release issued by bluebird bio, Inc. on February 18, 2020.
     104             Cover Page Interactive Data File (embedded within the Inline XBRL document)





--------------------------------------------------------------------------------

© Edgar Online, source Glimpses